NTRK Fusion Gene Positive Advanced Solid Tumor Market Analysis: Emerging Therapies and Forecast
The NTRK Fusion Gene Positive Advanced Solid Tumor Market is positioned for continued expansion as precision medicine, genomic diagnostics, and targeted oncology converge. WiseGuyReports forecasts growth from USD 2.0 billion in 2025 to USD 8.0 billion by 2035 at an 11.0% CAGR. A major future opportunity lies in developing therapies that address resistance mechanisms. Combination treatment...
0 Yorumlar 0 hisse senetleri 83 Views 0 önizleme